Patent · US Active

Anti-human folate receptor beta antibodies and methods of use

US8871206B2 · kind B2 · utility

1Cited by
0References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 8, 2013
Grant dateOct 28, 2014
Priority date
Expiry dateMar 8, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Human anti-human folate receptor beta (FRβ) antibodies and antigen-binding fragments thereof are described, as well as methods of using such antibodies and fragments to treat inflammatory disorders or cancers expressing cell surface FRβ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.